U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782944) titled 'CD38 Targeted -PET/ CT for Multiple Myeloma' on Aug. 20.
Brief Summary: The objective of the study is to construct a noninvasive approach CD38 targeted PET/CT to detect tumor lesions in patients with Multiple Myeloma and to compare with FDG PET/CT.
Study Start Date: July 07
Study Type: INTERVENTIONAL
Condition:
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Intervention:
DIAGNOSTIC_TEST: standard-of-care imaging (FDG PET/CT), CD38 PET/CT
Each subject receives a single intravenous injection of standard-of-care imaging radiopharmaceutical (FDG) and CD38, and undergoes PET/CT imaging within the specifie...